Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 680 participants.

Also called NCT07454980

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 680 participants (planned count) (from the registry)
Sponsor
Jenscare Innovation Inc. (from the registry)
Registry
  • NCT NCT07454980
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07454980. Randomized; single masking; primary purpose treatment. Start 2026-07-15 (actual); primary completion 2029-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)
Condition
Tricuspid Regurgitation (TR)
Intervention (Device)
TTVI with LuX-Valve Plus System
Intervention (Device)
TTVI with EVOQUE
Lead sponsor
Jenscare Innovation Inc. (class: industry)

Record details

Record id
cardio:ct-nct07454980
Content hash
476cdd29470ce157cbb9f08874f685b1849f2739cd59bfd87a35d16aa75bdf56